{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:57:36Z","timestamp":1787169456098,"version":"build-2736575974"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Myasthenia gravis (MG) patients with coronavirus disease (COVID-19) pose a unique challenge for intensive care management. Higher risk of infection is observed in patients with MG due to the immunosuppressant medications they are prescribed. The underlying component of respiratory muscle weakness predisposes these patients to experience a more severe form of illness. In the case of diagnosis of COVID-19 in MG patients, judicious continuation of immunosuppressants, avoiding drugs that worsen MG along with the continuation of cholinesterase inhibitors is prudent. Early diagnosis in cases with high-index of suspicion, extra precautions, COVID-appropriate behavior, and early immunization is paramount for the health of MG patients during this pandemic.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/aer.aer_129_21","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T08:40:01Z","timestamp":1646728801000},"page":"457-459","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Myasthenia Gravis and COVID-19 \u2013 A Clinical Checkmate"],"prefix":"10.4103","volume":"15","author":[{"given":"Vijayalakshmi","family":"Sivapurapu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratheeba","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra Raghuveera","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Remadevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20240901","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s13760-021-01662-w","article-title":"Case series of COVID-19 in patients with myasthenia gravis: A single institution experience","volume":"121","author":"\u017dupani\u0107","year":"2021","journal-title":"Acta Neurol Belg"},{"key":"R2-19-20240901","first-page":"8845844","article-title":"COVID-19 presentation in association with myasthenia gravis: A case report and review of the literature?","volume":"2020","author":"Aksoy","year":"2020","journal-title":"Case Rep Infect Dis"},{"key":"R3-19-20240901","doi-asserted-by":"crossref","first-page":"116888","DOI":"10.1016\/j.jns.2020.116888","article-title":"Myasthenic crisis in COVID-19","volume":"414","author":"Delly","year":"2020","journal-title":"J Neurol Sci"},{"key":"R4-19-20240901","doi-asserted-by":"crossref","first-page":"116803","DOI":"10.1016\/j.jns.2020.116803","article-title":"Guidance for the management of Myasthenia Gravis (MG) and Lambert-Eaton Myasthenic Syndrome (LEMS) during the COVID-19 pandemic","volume":"412","author":"Jacob","year":"2020","journal-title":"J Neurol Sci"},{"key":"R5-19-20240901","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1055\/s-0040-1714648","article-title":"The Neurocritical Care Society of India (NCSI) and the Indian Society of Neuroanaesthesiology and Critical Care (ISNACC) Joint position statement and advisory on the practice of neurocritical care during the COVID-19 pandemic","volume":"7","author":"Vanamoorthy","year":"2020","journal-title":"J Neuroanaesth Crit Care"},{"key":"R6-19-20240901","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3389\/fneur.2020.01053","article-title":"Myasthenia gravis and COVID-19: Clinical characteristics and outcomes","volume":"11","author":"Camelo-Filho","year":"2020","journal-title":"Front Neurol"},{"key":"R8-19-20240901","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3390\/jcm10071537","article-title":"Drugs that induce or cause deterioration of myasthenia gravis: An update","volume":"10","author":"Sheikh","year":"2021","journal-title":"J Clin Med"},{"key":"R9-19-20240901","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb Res"},{"key":"R10-19-20240901","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1136\/jnnp-2020-323565","article-title":"Management of patients with generalised myasthenia gravis and COVID-19: Four case reports","volume":"91","author":"H\u00fcbers","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R11-19-20240901","first-page":"e15581","article-title":"A case of COVID-19 vaccine causing a myasthenia gravis crisis","volume":"13","author":"Tagliaferri","year":"2021","journal-title":"Cureus"}],"container-title":["Anesthesia Essays &amp; Researches"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aer.aer_129_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:08:10Z","timestamp":1787166490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aer.aer_129_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/aer.aer_129_21","relation":{},"ISSN":["0259-1162"],"issn-type":[{"value":"0259-1162","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}